Vendor profile
Research · US · —
Shanghai ERP peptide Biotechnology
B+
Composite 8.6 / 10
Last updated 2026-08-17. Composite is computed from the live database; missing sub-scores redistribute weight across the others.
Peptide breakdown
| Peptide | Score | Lab quality | Tests | Purity | Qty var. | $/mg verified | Last test | Ranking |
|---|---|---|---|---|---|---|---|---|
| Tirzepatide | 9.1A |
8.9 | 18 | — | — | — | — | view |
| Retatrutide | 9.0A |
8.8 | 53 | — | — | — | — | view |
| GHK-Cu | 8.8B+ |
8.4 | 10 | — | — | — | — | view |
| BPC-157 | 7.4B |
6.7 | 6 | — | — | — | — | view |
| Tesamorelin | 7.2B |
6.5 | 10 | — | — | — | — | view |
| TB-500 | 5.0D |
3.7 | 5 | — | — | — | — | view |
| Ipamorelin | — |
— | 0 | — | — | — | — | view |
| MOTS-c | — |
— | 0 | — | — | — | — | view |
| Epitalon | — |
— | 0 | — | — | — | — | view |
| CJC-1295 | — |
— | 0 | — | — | — | — | view |
| Semaglutide | — |
— | 0 | — | — | — | — | view |
| Sermorelin | — |
— | 0 | — | — | — | — | view |
| PT-141 | — |
— | 0 | — | — | — | — | view |
COA transparency
- ○ Publishes per-batch COAs (not just one COA for everyone) (pending)
- ○ Both HPLC and mass spec shown (pending)
- ○ Endotoxin or sterility data shown (pending)
- ○ At least one COA independently cross-checked (pending)
- ○ Most recent COA within 90 days (pending)
All vendor grades, side-by-side
Compare Shanghai ERP peptide Biotechnology against every other vendor in the grade hub →
Top-5 ranked vendors per peptide, plus the highest-rated vendors overall. Daily refresh.